Dr Brian Stickle - PowerPoint PPT Presentation

1 / 65
About This Presentation
Title:

Dr Brian Stickle

Description:

Modes / routes of drug delivery 'Pain is an unpleasant sensory and emotional experience associated with actual or ... sedation, euphoria, dysphoria, N&V, miosis. GU/GI ... – PowerPoint PPT presentation

Number of Views:80
Avg rating:3.0/5.0
Slides: 66
Provided by: brians53
Category:
Tags: brian | miosis | stickle

less

Transcript and Presenter's Notes

Title: Dr Brian Stickle


1
Pain
Physiology And Pharmacology
  • Dr Brian Stickle
  • Consultant Anaesthetist
  • Acute Pain Team
  • Department of Anaesthesia
  • ARI

2
Contents
  • Physiology of Pain
  • Recap
  • Pharmacology
  • Opiates
  • NSAIDs (inc paracetamol)?
  • Tramadol
  • Modes / routes of drug delivery

3
Definition
Pain is an unpleasant sensory and emotional
experience associated with actual or potential
tissue damage or described in terms of such
damage.
  • International Association for the Study of Pain
  • Implies emotional component.
  • Pain can exist without tissue damage.

4
(No Transcript)
5
Peripheral Modulation of Pain
  • Tissue damage
  • Release of inflammatory mediators
  • Increased blood vessel permeability
  • Swelling / Oedema
  • Vasodilation
  • Redness
  • Stimulated inflammatory process
  • Immune response white cell activation
  • Phagocytosis
  • Sensitisation of nerve endings
  • Tenderness

6
Peripheral modulation of pain
Tissue injury
Blood Vessel
Tissue
PGs, leukotrienes
Oedema
Plasma extravasation
Nerve terminal
Bradykinin
SP NKA CGRP
Mast cell
Spinal cord
Histamine
5HT
platelet
7
Spinal ModulationGate Control Theory
Central control
Gate control System
-

Fast fibres touch / pressure

Action System
T
PAIN
SG
-
Slow pain fibres
-

8
Descending control
  • Motor System
  • release of spinal cord reflexes
  • loss of tonic descending control hyperreflexia
  • Sensory System
  • descending inhibitory systems
  • stop pain transmission
  • loss of inhibition pain
  • transmission noradrenaline, 5HT

9
Descending control
10
Central Modulation of Pain
  • Thalamic Gate
  • opiates
  • Peri-aqueductal grey matter
  • opiate gating (? principal site of action)?
  • switch on off neurones
  • switch off on neurones

11
Wind - Up
  • Pain input into cord influences pain transmission
  • NMDA mediated
  • Increased sensitivity and increased transmission
  • i.e. pain can be self amplifying

12
Pre-emptive analgesia
  • Block nociceptive input into cord blocks
    wind-up
  • Experimental evidence good
  • No evidence in humans
  • No good trials in humans (yet)?
  • ? How much stimulation required
  • Other factors ?

13
Analgesic Drugs
14
NSAIDs
  • Non Steroidal Anti-Inflammatory Drugs
  • willow bark - salicin
  • Cyclo-oxygenase inhibitors
  • Sole therapy for mild/moderate pain
  • Combination therapy balanced analgesia

15
COX inhibition and NSAIDs
  • ? Most likely mechanism for NSAID-mediated
    analgesia.
  • Selective COX-2 inhibitors should produce
    analgesia with fewer adverse effects.

16
NSAID Side effects
  • Respiratory
  • aspirin sensitive asthma
  • GI
  • peptic ulceration stomach duodenum
  • Renal
  • removes vasodilatory prostaglandins
  • precipitate ARF in susceptible Patients
  • impaired renal blood flow
  • dehydration
  • impaired renal function
  • other nephrotoxic therapies

17
Paracetamol
  • The most under-rated drug in the BNF
  • Stickle, B.R. 1996 (and loads of times since)?
  • Inhibits central COX
  • BUT - role of central COX unclear
  • Analgesic
  • Antipyretic
  • No peripheral effects
  • No toxicity in therapeutic doses (?)?

18
Opiates Sites of action
  • Central
  • PAGM
  • Switch off on cells
  • Switch on off cells
  • Spinal
  • Gating function Inhibits release of
    neurotransmitters involved in pain transmission
  • Peripheral
  • receptors only active in inflammatory states

19
Opiate Side Effects
  • Side effects
  • Respiratory depression
  • antagonised by pain
  • all opiates the same at equianalgesic doses
  • risk small if properly titrated
  • CVS
  • vasodilatation, bradycardia, myocardial
    depression
  • CNS
  • sedation, euphoria, dysphoria, NV, miosis
  • GU/GI
  • urinary retention, decreased GI motility, spasm
    of sphincter of Oddi

20
Tramadol
  • Weak µ agonist (1/6000 v morphine)?
  • selective µ agonist
  • pure agonist activity
  • 30 of effect antagonised by naloxone
  • Noradrenaline reuptake inhibitor
  • 5-HT reuptake inhibitor
  • Non-controlled drug

21
Descending control
22
Tramadol
  • Advantages
  • lack of respiratory depression
  • less sedative vs morphine
  • ? less N V
  • less GI SFX
  • non-controlled drug
  • oral preparation effective
  • Disadvantages
  • slightly less potent vs morphine
  • slower onset times
  • cost

23
(No Transcript)
24
Ketamine
  • NMDA receptor antagonist
  • NMDA receptors shown to have role in development
    of hyperalgesia
  • Blockade of NMDA receptors may prevent
    development of opioid tolerance
  • Established opioid sparing effect

25
Ketamine
  • General anaesthetic agent
  • Doses typically 1-2mg/kg
  • Atypical
  • Preserves CVS / resp function
  • Airway reflexes / patency generally preserved
  • Analgesic
  • Bronchodilator
  • Famous side effects
  • Hallucinations

26
Ketamine
  • Analgesic at low doses
  • 10 of anaesthetic doses
  • LOADS of studies
  • Cochrane review
  • It works
  • 30-50 reduction in opiate doses
  • Reduced PONV

27
Ketamine
  • How to give it?
  • Single dose ?
  • Continuous infusion ?
  • Added to PCA X
  • Epidurally ? ?

28
Ketamine Side effects?
  • Doses low
  • Tolerability good in all trials
  • Reduced PONV pruritis
  • Some increased sedation
  • Low incidents of hallucination / vivid dreaming

29
Ketamine
  • Proven adjuvant in opioid tolerance in chronic
    and cancer pain
  • Poorly studied in acute pain
  • But
  • Significant reduction in opioid requirements in
    positive studies
  • Anecdotally effective

30
Choice of drug(s)?
  • Patient Factors
  • severity
  • site
  • patient requirements
  • co-existing illness / disease
  • available routes
  • Other factors
  • facilities
  • equipment
  • staff
  • time

31
Balanced Analgesia
  • Concept of combination therapy
  • Advantages
  • Reduction in SFX
  • minimising doses, synergy
  • Improved analgesia
  • Disadvantages
  • Multiplication of SFX
  • Cost
  • Polypharmacy

32
Balanced Analgesia
33
Modes of delivery
  • Regular(bd, tds, qds)?
  • PRN
  • (Patient receives NONE)?
  • Slow release
  • Infusion
  • PCA
  • IV, Epidural

34
Hierarchical Mx
Increasing Pain severity
  • Severe
  • NSAIDs
  • Tramadol
  • Opiates
  • PCA
  • Epidural
  • Mild
  • Oral analgesia
  • NSAIDs
  • Weak opiates
  • Moderate
  • NSAIDs
  • Tramadol
  • Opiates
  • IM/PCA

Increasing potency combinations
35
Balanced analgesia ?
Opiate
Plus
(maybe)?
As required
36
Balanced analgesia - really
NSAID Paracetamol
Regularly
And
As required opiate
37
Balanced analgesia regimes
Weak Oral Opioid Codeine 30 60 mg 6 hrly
Dihydrocodeine 30mg 6 hrly
Mild pain Minor surgery
All Patients
Adjuvant Analgesic Regular Paracetamol and/or
NSAID
SC, IM or Oral morphine
Mod pain Intermed surgery
PCAS Morphine / Epidural
Severe pain Major surgery
38
Routes of delivery
  • Oral
  • Rectal
  • Subcutaneous
  • Transdermal
  • Intramuscular
  • Intravenous
  • Epidural
  • Intra-spinal

39
IM Morphine
Effective Plasma Concentration
Morphine concentration
3 hours
Time
40
Intermittent subcut / IM
41
PCA Morphine
Effective Plasma Concentration
Morphine concentration
Time
bolus 1mg
42
Sustained release oral opiate
Effective Plasma Concentration
Plasma morphine concentration
4
8
12
Time
43
Sustained release supplement
Effective Plasma Concentration
Plasma morphine concentration
4
8
12
Time
44
?
45
Summary
  • Pain pathway vulnerable at a number of points
  • Peripheral sensitisation primary problem
  • Transmission can be modulated spinally and
    centrally
  • Combination therapy
  • Maximises analgesia
  • Minimises side effects

46
(No Transcript)
47
Local Anaesthesia and Epidural Blocks
48
Balanced Analgesia
49
Local Anaesthetics
  • Lignocaine, bupivacaine, prilocaine.
  • Sodium channel blockers
  • Pharmacologically filthy !!!
  • Prevent propagation of action potential
  • LA molecules must pass into axon to block sodium
    channel from within.

50
Local anaesthetics
Na
depolarisation
Na
un-ionised ionised
51
LA Differential Blockade
  • Due to differential penetration into different
    nerve types
  • Myelinated, thick fibres Relatively spared
  • Motor fibres spared (relatively)?
  • Pain fibres blocked easily (luckily)?

52
Local anaesthetics
  • Limiting factor in use is toxicity
  • Toxicity - high plasma levels
  • Intravenous injection
  • Absorption gt rate of metabolism high plasma
    levels
  • ??vasoconstrictors - reduce blood flow, reduce
    absorption.
  • Toxicity depends on-
  • dose used
  • rate of absorption
  • patient weight
  • drug ( bupivacaine gt lignocaine gt prilocaine )?

53
Regional local anaesthesia
  • Retain awareness / consciousness
  • Lack of global effects of systemic analgesics
  • Derangement of CVS physiology
  • proportional to size of anaesthetised area
  • Relative sparing of respiratory function

54
Regional local anaesthesia
  • Local anaesthesia
  • Field blocks
  • hernia repair
  • Plexus blocks
  • Limb blocks
  • e.g. femoral N sciatic N
  • Central neural (neuraxial) block
  • epidural
  • spinal

Increasing physiological impact
55
Spinal canal
56
Postoperative epidural analgesia
  • Proven benefit in certain groups of patients
  • ? Proven benefit for certain ops
  • High incidence of minor CVS side effects
  • Low incidence of major CNS side effects
  • Haematoma / abscess

57
Epidural advantages
  • Gold standard analgesia
  • Improved co-operation with physiotherapy /
    nursing staff
  • Avoid systemic opiates
  • Less sedation
  • Less interference with resp function

58
Epidural opiates
  • Act on spinal cord
  • Improve quality of analgesia
  • Relative lack of systemic effects
  • But-
  • Pruritis
  • High incidence of respiratory depression when
    combined with systemic opiates.

59
Epidural infusions
  • Short half life of LA / opiate in epidural space
    (3-4 hours)?
  • Repeated top ups
  • less stable block
  • breakthrough pain
  • Infusion
  • requires kit
  • Rate can be variable (sliding scale)?
  • Tachyphlaxis

60
Physiology of neuraxial block CVS
Venodilation
MAP CO SVR
Arteriolar vasodilation
61
Signs and symptoms of local anaesthetic toxicity
  • Circumoral and lingual numbness and tingling
  • Light-headedness
  • Tinnitus, visual disturbances
  • Muscular twitching
  • Drowsiness
  • Cardiovascular depression
  • Convulsions
  • Coma
  • Cardiorespiratory arrest

62
(No Transcript)
63
Scenario 1
  • 26 y/o asthmatic man
  • Appx. Given IM Morphine 10mg 4 hourly. Pain
    scores 3-4

64
Scenario 2
  • 80 y/o lady. No sig PMH.
  • Hemiarthroplasty. No analgesia prescribed.
    Spinal anaesthetic wearing off. Not PU'd.

65
Scenario 3
  • 56 y/o man. Metastatic lung Ca.
  • Pathological femur. IM Nail
  • Normally has MXL 150mg

66
Scenario 4
  • 75 y/o lady. L hemi-colectomy.
  • PCA Morphine. Sedated .
  • Pain scores 3-4 (when awake !!)?

67
Scenario 5
  • 65 y/o lady. Longstanding pain in right hip.
  • Takes paracetamol occasionally codeine 30mg
    prn.
  • Pain worsening recently interfering with daily
    living
Write a Comment
User Comments (0)
About PowerShow.com